Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020005 · ClinicalTrials.gov registry record · NA
Evaluation of Cessation Preferences of Menthol Smoker
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02020005: Completed NA study, sponsored by University of Minnesota.
NCT02020005 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02020005, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary aim of this study is to determine menthol smokers' perception, product preference, and pattern of use across six products including, mint-flavored nicotine gum; non-flavored nicotine gum; mentholated nicotine inhaler; and non-menthol nicotine inhaler. Participants will undergo an orientation and baseline assessment followed by a 2-week product sampling phase. At the end of the 2 weeks of sampling, subjects will select a product to use during the following 2-week smoking cessation phase. This 2-week abstinence phase is followed by one week of abrupt withdrawal of the product. This study design was successfully used in a study we conducted that examined the smokers' preference for a variety or oral tobacco products.
Primary Outcome
To determine menthol smokers' product perception and preference across 6 different types of products with varying mint content.
Interventions
- OTHER Non-flavored 2mg nicotine gum
- OTHER Non-flavored 4mg nicotine gum
- OTHER Mint-flavored 2mg nicotine gum
- OTHER Mint-flavored 4mg nicotine gum
- OTHER Non-flavored nicotine inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-09 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT02020005 record still lists
NCT02020005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Non-flavored 2mg nicotine gum is the first listed.
NCT02020005 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02020005 about?
NCT02020005 is a clinical study titled "Evaluation of Cessation Preferences of Menthol Smoker". The primary aim of this study is to determine menthol smokers' perception, product preference, and pattern of use across six products including, mint-flavored nicotine gum; non-flavored nicotine gum; mentholated nicotine inhaler; and non-menthol nicotine inhaler. Participants will undergo an orienta...
What is the current status of trial NCT02020005?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02020005?
The interventions under investigation include: Non-flavored 2mg nicotine gum (OTHER), Non-flavored 4mg nicotine gum (OTHER), Mint-flavored 2mg nicotine gum (OTHER), Mint-flavored 4mg nicotine gum (OTHER), Non-flavored nicotine inhaler (OTHER).
Who is sponsoring clinical trial NCT02020005?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02020005's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia